BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 15936582)

  • 1. Randomized trial of high- and low-source strength (125)I prostate seed implants: In regard to Narayana et al. (Int J Radiat Oncol Biol Phys 2005;61:44-51).
    Moerland MA; Battermann JJ
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):941-2. PubMed ID: 15936582
    [No Abstract]   [Full Text] [Related]  

  • 2. In regards to Wallner et al: (125)I versus (103)PD for low-risk prostate cancer: preliminary PSA outcomes from a prospective randomized multicenter trial (Int J Radiat Oncol Biol Phys 2003;57:1297-1303).
    Lee WR
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):319; author reply 319-20. PubMed ID: 15093929
    [No Abstract]   [Full Text] [Related]  

  • 3. Brachytherapy doses for prostate cancer customized to risk factors: is it more important "how much" or "where"? In regard to Stone et al. (Int J Radiat Oncol Biol Phys 2007;69:1472-1477).
    Oton CA; Oton F
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):962; author reply 962-3. PubMed ID: 18514795
    [No Abstract]   [Full Text] [Related]  

  • 4. Prostate brachytherapy as monotherapy: Are there gaps, holes, and islands in the argument? In regard to Wallner et al. (Int J Radiat Oncol Biol Phys 2003;57:1297-1303).
    Rubenstein J
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):305; author reply 305-6. PubMed ID: 15629630
    [No Abstract]   [Full Text] [Related]  

  • 5. In regard to Anagnostopoulos et al.: In vivo thermoluminescence dosimetry dose verification of transperinal (192)Ir high dose rate brachytherapy using CT-based planning for the treatment of prostate cancer (Int J Radiat Oncol Biol Phys 2003;57:1183-1191).
    Duggan L; Bucci J; Kron T
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):911; author reply 911-2. PubMed ID: 15183495
    [No Abstract]   [Full Text] [Related]  

  • 6. In regard to correspondence between Pötter et al. and Nag et al. (Int J Radiat Oncol Biol Phys 2005;62:293-295).
    Narayan K; vanDyk S; Bernshaw DL
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):644-5; author reply 645-7. PubMed ID: 16168857
    [No Abstract]   [Full Text] [Related]  

  • 7. In regard to Chen et Al. (Int J Radiat Oncol Biol Phys 2007;69:25-31) and Chao et Al. (Int j Radiat Oncol Biol Phys 2007;69:32-40).
    Yaeger TE
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):317; author reply 317-8. PubMed ID: 18406902
    [No Abstract]   [Full Text] [Related]  

  • 8. Recommendations for image-based intracavitary brachytherapy of cervix cancer: the GYN GEC ESTRO Working Group point of view: in regard to Nag et al. (Int J Radiat Oncol Biol Phys 2004;60:1160-1172).
    Pötter R; Dimopoulos J; Kirisits C; Lang S; Haie-Meder C; Briot E; Dumas I; Van Limbergen E; De Brabandere M; Nulens A; Erickson B; Rownd J; Petrow P
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):293-5; author reply 295-6. PubMed ID: 15850940
    [No Abstract]   [Full Text] [Related]  

  • 9. In regard to Kupelian et al.: Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seed/external beam radiotherapy for stage T1-T2 prostate cancer (Int J Radiat Oncol Biol Phys 2004;58:25-33).
    Halperin RM
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):631-2; author reply 632. PubMed ID: 15667989
    [No Abstract]   [Full Text] [Related]  

  • 10. Randomized trial of high- and low-source strength (125)I prostate seed implants.
    Narayana V; Troyer S; Evans V; Winfield RJ; Roberson PL; McLaughlin PW
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):44-51. PubMed ID: 15629592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is a "Puff to the Cuff" enough?: In regard to Alektiar et al. (Int J Radiat Oncol Biol Phys 2005;62: 111-117).
    Greven KM
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1275; author reply 1275. PubMed ID: 16253783
    [No Abstract]   [Full Text] [Related]  

  • 12. Volumetric modulated arc therapy for delivery of prostate radiotherapy: in regard to Palma et al. (Int J Radiat Oncol Biol Phys 2008;70:996-1001).
    Ost P; Fonteyne V; De Neve W; De Gersem W; De Wagter C; Vandecasteele K; Duprez F; De Meerleer G
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1286; author reply 1287. PubMed ID: 19251105
    [No Abstract]   [Full Text] [Related]  

  • 13. In regard to Fiorino et al.: Rectal dose-volume constraints in high-dose radiotherapy of localized prostate cancer (Int J Radiat Oncol Biol Phys 2003;57:953-962).
    Bauman G; Rodrigues G
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):912-4; author reply 914-5. PubMed ID: 15183497
    [No Abstract]   [Full Text] [Related]  

  • 14. Re: Dosimetric consequences of increased seed strength for I-125 prostate implants. Radiother Oncol. 2003 Sep;68(3):295-7.
    Lee WR
    Radiother Oncol; 2004 Feb; 70(2):209-10; author reply 210. PubMed ID: 15028411
    [No Abstract]   [Full Text] [Related]  

  • 15. A permanent breast seed implant as partial-breast radiation therapy for early-stage patients: in regards to Keller et al. (Int J Radiat Oncol Biol Phys 2005;62:358-365).
    Godinez J; Gombos EC
    Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1611; author reply 1611. PubMed ID: 16580512
    [No Abstract]   [Full Text] [Related]  

  • 16. In regard to Trofimov et al.: Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: a treatment planning comparison (Int J Radiat Oncol Biol Phys 2007;69:444-453).
    Albertini F; Lomax AJ; Hug EB
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1333-4; author reply 1334-5. PubMed ID: 17967323
    [No Abstract]   [Full Text] [Related]  

  • 17. Androgen Deprivation (AD) among low-risk and intermediate-risk prostate cancer patients: in regard to Ciezki et al. (Int J Radiat Oncol Biol Phys 2004;60:1347-1350).
    Oton CA
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):291-2; author reply 292. PubMed ID: 15850937
    [No Abstract]   [Full Text] [Related]  

  • 18. Transperineal injection of hyaluronic acid in anterior perirectal fat to decrease rectal toxicity from radiation delivered with intensity-modulated brachytherapy or EBRT for prostate cancer patients: in regard to Prada et al. (Int J Radiat Oncol Biol Phys 2007;69:95-102.).
    Vordermark D; Guckenberger M; Baier K; Markert K
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):316-7. PubMed ID: 18406899
    [No Abstract]   [Full Text] [Related]  

  • 19. Adjuvant malignant mesothelioma radiotherapy: How many difficulties! In regard to: Allen et al. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma (Int J Radiat Oncol Biol Phys 2006;65:640-645) and Gupta et al. Hemithoracic radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma (Int J Radiat Oncol Biol Phys 2005;63:1045-1052).
    Russi EG; Pergolizzi S; Lucio F; Ricardi U
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1273-4; author reply 1274. PubMed ID: 17145545
    [No Abstract]   [Full Text] [Related]  

  • 20. A marginal issue: in regard to Wolden et al. (Int J Radiat Oncol Biol Phys 2005;61:1432-1438).
    Scarbrough TJ; Thomas CR
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):647-8; author reply 648-9. PubMed ID: 16168860
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.